Clinuvel Pharmaceuticals Limited American Depositary Shares (CUVL)

Clinuvel Pharmaceuticals Limited American Depositary Shares (CUVL) is a Biotechnology company in the Healthcare sector listed on the US.

As of Oct 23, 2026: market cap $262M; returns 1 day -1.8%, 1 week -5.6%.

Clinuvel Pharmaceuticals Limited is a global biopharmaceutical company specializing in photomedicine and the development of melanocortin peptide therapies for rare genetic and metabolic disorders.

Groups CUVL belongs to

• Dividend Payers
• Biopharmaceutical
• Biotechnology
• Pharmaceuticals
• Healthcare
• Rare Diseases
• Commercial Stage Biotech
• Dermatology
• Unmet Medical Needs
• Clinical Stage Biopharma
• Vertical Integration

CUVL financial model: income statement, cash flow and balance sheet